These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2162318)

  • 41. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
    Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ovarian surface epithelial neoplasms in the pediatric population: incidence, histologic subtype, and natural history.
    Hazard FK; Longacre TA
    Am J Surg Pathol; 2013 Apr; 37(4):548-53. PubMed ID: 23388124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?
    Kajiyama H; Mizuno M; Shibata K; Umezu T; Suzuki S; Yamamoto E; Mitsui H; Sekiya R; Niimi K; Kawai M; Nagasaka T; Kikkawa F
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():305-10. PubMed ID: 25203309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant hypermethylation of RASSF1A promoter in ovarian borderline tumors and carcinomas.
    Choi YL; Kang SY; Shin YK; Choi JS; Kim SH; Lee SJ; Bae DS; Ahn G
    Virchows Arch; 2006 Mar; 448(3):331-6. PubMed ID: 16315018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
    Prayson RA; Hart WR; Petras RE
    Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential.
    Ronnett BM; Kurman RJ; Zahn CM; Shmookler BM; Jablonski KA; Kass ME; Sugarbaker PH
    Hum Pathol; 1995 May; 26(5):509-24. PubMed ID: 7750935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FOXA1 is expressed in ovarian mucinous neoplasms.
    Karpathiou G; Venet M; Mobarki M; Forest F; Chauleur C; Peoc'h M
    Pathology; 2017 Apr; 49(3):271-276. PubMed ID: 28238418
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of epidemiological factors between serous and mucinous borderline ovarian tumors: therapeutic implications].
    Fauvet R; Demblocque É; Morice P; Querleu D; Gondry J; Daraï É
    Bull Cancer; 2012 May; 99(5):551-6. PubMed ID: 22510207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocervical-like mucinous borderline tumors of the ovary: clinicopathological features and electron microscopic findings.
    Moriya T; Mikami Y; Sakamoto K; Endoh M; Takeyama J; Suzuki T; Mochizuki S; Watanabe M; Monobe Y; Sasano H
    Med Electron Microsc; 2003 Dec; 36(4):240-6. PubMed ID: 16228656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-malignant potential epithelial tumors of the ovary: a clinicopathological study.
    Hassan E; Koumantaki Y; Stefanaki K; Matalliotakis I; Koumantakis E
    Eur J Gynaecol Oncol; 1998; 19(2):170-2. PubMed ID: 9611060
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of stage III mucinous and serous ovarian cancer: a case-control study.
    Firat Cuylan Z; Karabuk E; Oz M; Turan AT; Meydanli MM; Taskin S; Sari ME; Sahin H; Ulukent SC; Akbayir O; Gungorduk K; Gungor T; Kose MF; Ayhan A
    J Ovarian Res; 2018 Oct; 11(1):91. PubMed ID: 30376858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis.
    Tanaka YO; Okada S; Satoh T; Matsumoto K; Oki A; Saida T; Yoshikawa H; Minami M
    Cancer Imaging; 2016 Feb; 16():3. PubMed ID: 26873307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
    Cuff J; Longacre TA
    Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Borderline ovarian tumors and global radiation in relation with climate change impact].
    Luchian AM; Pricop M
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):813-9. PubMed ID: 22046792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FGF18 as a potential biomarker in serous and mucinous ovarian tumors.
    El-Gendi S; Abdelzaher E; Mostafa MF; Sheasha GA
    Tumour Biol; 2016 Mar; 37(3):3173-83. PubMed ID: 26427667
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Borderline Brenner Tumor of the Ovary Coexisting With an Ovarian Mucinous Cystadenoma With Focal Atypical Epithelial Proliferation: A Rare Case With Review of the Literature.
    Salibay CJ; Zanfagnin V; Miller H; Walia S; Brunette LL; Wang T
    Int J Surg Pathol; 2021 Oct; 29(7):788-793. PubMed ID: 33635096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mucinous Neoplasms of the Ovary: Radiologic-Pathologic Correlation.
    Marko J; Marko KI; Pachigolla SL; Crothers BA; Mattu R; Wolfman DJ
    Radiographics; 2019; 39(4):982-997. PubMed ID: 31283462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell proliferation activity unrelated to COX-2 expression in ovarian tumors.
    Yoshida A; Sarian LO; Andrade LA; Pignataro F; Pinto GA; Derchain SF
    Int J Gynecol Cancer; 2007; 17(3):607-14. PubMed ID: 17504375
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seromucinous ovarian tumor A comparison with the rest of ovarian epithelial tumors.
    Karpathiou G; Chauleur C; Corsini T; Venet M; Habougit C; Honeyman F; Forest F; Peoc'h M
    Ann Diagn Pathol; 2017 Apr; 27():28-33. PubMed ID: 28325358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types.
    Kabawat SE; Bast RC; Welch WR; Knapp RC; Colvin RB
    Am J Clin Pathol; 1983 Jan; 79(1):98-104. PubMed ID: 6336888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.